ArticleNature communications2013

Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.

Tetsuro Yoshimaru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.